The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, D. S.
Right arrow Articles by Kornbluth, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, D. S.
Right arrow Articles by Kornbluth, J.

The Journal of Immunology, Vol 139, Issue 6 1792-1796, Copyright © 1987 by American Association of Immunologists


ARTICLES

Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes

DS Taylor, PC Nowell and J Kornbluth

The role of major histocompatibility complex-encoded class I molecules in the proliferation of human B lymphocytes is presently unclear. This question was addressed by investigating the effect of three individually derived anti-HLA class I monoclonal antibodies (mAb) on purified human B cells (less than 1.5% T cells) stimulated by either the T-independent mitogen Staphylococcus aureus or the phorbol ester, phorbol-12-myristate-13-acetate. The three anti-HLA class I antibodies, whether specific for gene products of the HLA-A locus (mAb 131), HLA-B locus (mAb 4E), or HLA-A, -B, and -C locus (mAb W6/32), inhibited S. aureus-induced proliferation by 70 to 90%. This inhibition was significant over a 5-day culture period, was not altered by the addition of exogenous interleukin 2 or B cell growth factor, and was not due to nonspecific cytotoxicity. In addition, the inhibition of proliferation was unchanged when the mAb were added 12 hr after the initiation of culture. The proliferative response was not affected by either of the control antibodies OKB7 and R3-367. In contrast with S. aureus-stimulated B cells, phorbol-12-myristate-13-acetate-induced proliferation was resistant to the inhibitory activity of HLA class I- specific antibodies. These results suggest that HLA class I molecules are involved in human B lymphocyte proliferation and may regulate a critical event preceding the upregulation of protein kinase C activity.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
G. Rubio, X. Ferez, M. Sanchez-Campillo, J. Galvez, S. Marti, R. Verdu, T. Hernandez-Caselles, and P. Garcia-Penarrubia
Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines
J. Leukoc. Biol., July 1, 2004; 76(1): 116 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Frumento, L. Ottonello, M. Bertolotto, S. Franchello, G. Melioli, and F. Dallegri
Spontaneous apoptosis in neutrophils is associated with downregulation of HLA Class I and is prevented by ligation of Class I
J. Leukoc. Biol., December 1, 2000; 68(6): 873 - 880.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. Bian and E. F. Reed
Alloantibody-Mediated Class I Signal Transduction in Endothelial Cells and Smooth Muscle Cells: Enhancement by IFN-{gamma} and TNF-{alpha}
J. Immunol., July 15, 1999; 163(2): 1010 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. D. Pettersen, G. Gaudernack, M. K. Olafsen, S. O. Lie, and K. Hestdal
The TCR-Binding Region of the HLA Class I {alpha}2 Domain Signals Rapid Fas-Independent Cell Death: A Direct Pathway for T Cell-Mediated Killing of Target Cells?
J. Immunol., May 1, 1998; 160(9): 4343 - 4352.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.